The third stage of research on the Russian Sputnik V coronavirus vaccine will begin within a maximum of ten days,  Alexander Gintsburg, director of the National Research Center for Epidemiology and Microbiology named after N. F. Gamaleya said. Research will be carried out in the Moscow region with the participation of tens of thousands of people. The civil circulation of the vaccine will be launched one month after the start of the post-registration stage.

      “Based on such a great interest and attention of the public and the press to this, I think that the Ministry of Health will not drag out and will approve the protocol for us within a week. So I think, within seven, maximum ten days, it will all start...” Mr. Gunzburg said. According to him, the financial part is being specified now, because "it costs a lot of money."  The Moscow region has all the necessary infrastructure for the research.

      Earlier Roszdravnadzor reported that 2 thousand people will take part in post-registration studies. The Russian vaccine was registered as the first   in the world on August 11. Its production started on August 15.